Decreased hypothalamic functional connectivity with subgenual cortex in psychotic major depression

Neuropsychopharmacology

Volumn 40, Issue 4, 2015, Pages 849-860

  Sudheimer, Keith ^a,b   Keller, Jennifer ^a   Gomez, Rowena ^a   Tennakoon, Lakshika ^a   Reiss, Allan ^a   Garrett, Amy ^a   Kenna, Heather ^a   O'Hara, Ruth ^a,b   Schatzberg, Alan F ^a  

^a STANFORD UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; ANTIDEPRESSANT AGENT; OXYGEN;

ADULT; AGED; ARTICLE; BRAIN ANALYSIS; BRAIN CORTEX; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PSYCHOSIS; RESTING STATE NETWORK; SUBGENUAL CORTEX; ADOLESCENT; BLOOD; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; FOLLOW UP; IMAGE PROCESSING; MIDDLE AGED; NERVE TRACT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; REST; VASCULARIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BRAIN MAPPING; CEREBRAL CORTEX; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; HYPOTHALAMUS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; OXYGEN; REST; YOUNG ADULT;

EID: 84925483321     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.259     Document Type: Article

References (34)

1. Carroll BJ, Curtis GC, Davies BM, Mendels J, Sugerman AA (1976). Urinary free cortisol excretion in depression. Psychol Med 6: 43-50.
2. Damasio H (1995). Human Brain Anatomy in Computerized Images. Oxford University Press: New York.
3. Grecius M, Flores B, Menon V, Glover G, Solvason B, Kenna H et al (2007). Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 62: 429-437.
4. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z (1983). Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch Gen Psychiatry 40: 493-500.
5. Hamani C, Mayberg H, Stone S, Laxton A, Haber S, Lozano AM (2011). The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry 69: 301-308.
6. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
7. Johansen-Berg H, Gutman DA, Behrens TEJ, Matthews PM, Rushworth MFS, Katz E et al (2008). Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex 18: 1374-1383.
8. Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH et al (2006). Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry 60: 275-281.
9. Lane RD, Weidenbacher H, Smith R, Fort C, Thayer JF, Allen JJB (2013). Subgenual anterior cingulate cortex activity covariation with cardiac vagal control is altered in depression. J Affect Disord 150: 565-570.
10. Lembke A, Gomez R, Tenakoon L, Keller J, Cohen G, Williams GH et al (2012). The mineralocorticoid receptor agonist, fludrocor-tisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendo-crinology 38: 115-121.
11. Lozano AM, Giacobbe P, Hamani C, Rizvi SJ, Kennedy SH, Kolivakis TT et al (2012). A multicenter pilot study of sub-callosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg 116: 315-322.
12. Macey PM, Macey KE, Kumar R, Harper RM (2004). A method for removal of global effects from fMRI time series. Neuroimage 22: 360-366.
13. Mai JK, Assheuer J, Paxinos G1 (1997). Atlas of the Human Brain. Academic Press: San Diego, CA.
14. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL et al (1997). Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8: 1057-1061.
15. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA et al (1999). Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156: 675-682.
16. Nelson JC, Davis JM (1997). DST studies in psychotic depression: a meta-analysis. Am J Psychiatry 154: 1497-1503.
17. Ohayon MM (2002). Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry 159: 1855-1861.
18. Ongür D, An X, Price JL (1998a). Prefrontal cortical projections to the hypothalamus in macaque monkeys. J Comp Neurol 401: 480-505.
19. Ongür D, Drevets WC, Price JL (1998b). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95: 13290-13295.
20. Osuch EA, Ketter TA, Kimbrell TA, George MS, Benson BE, Willis MW et al (2000). Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol Psychiatry 48: 1020-1023.
21. Patel PD, Lopez JF, Lyons DM, Burke S, Wallace M, Schatzberg AF (2000). Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res 34: 383-392.
22. Phan KL, Wager T, Taylor SF, Liberzon I (2002). Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 16: 331-348.
23. Rempel-Clower NL, Barbas H (1998). Topographic organization of connections between the hypothalamus and prefrontal cortex in the rhesus monkey. J Comp Neurol 398: 393-419.
24. Rhoades HM, Overall J (1988). The semistructured BPRS interview and rating guide. Psychopharmacol Bull 24: 101-104.
25. Stetler C, Miller GE (2011). Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 73: 114-126.
26. Sudheimer K, Winn B, Garrett K, Shoaps J, Davies K, Fobbs A. The Human Brain Atlas, Michigan State University. Available at ohttps://www.msu.edu/Bbrains/brains/human/index.html4.
27. Sudheimer KD, Abelson JL, Taylor SF, Martis B, Welsh RC, Warner C et al (2013). Exogenous glucocorticoids decrease subgenual cingulate activity evoked by sadness. Neuropsycho-pharmacology 38: 826-845.
28. Thase ME, Hersen M, Bellack AS, Himmelhoch JM, Kupfer DJ (1983). Validation of a Hamilton subscale for endogenomorphic depression. J Affect Disord 5: 267-278.
29. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcella-tion of the MNI MRI single-subject brain. Neuroimage 15: 273-289.
30. Veazey RB, Amaral DG, Cowan WM (1982). The morphology and connections of the posterior hypothalamus in the cynomolgus monkey (Macaca fascicularis). II. Efferent connections. J Comp Neurol 207: 135-156.
31. Watzka M, Bidlingmaier F, Beyenburg S, Henke RT, Clusmann H, Elger CE et al (2000). Corticosteroid receptor mRNA expression in the brains of patients with epilepsy. Steroids 65: 895-901.
32. Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS (2002). Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 7: 985-994 924.
33. Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M (2001). Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J Psychiatr Res 35: 83-94.
34. Zobel AW, Yassouridis A, Frieboes RM, Holsboer F (1999). Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am J Psychiatry 156: 949-951.